James C. Foster

All filings by James C. Foster on record concern Charles River Laboratories International, Inc., in the capacity of chief executive. Over a trading history stretching from 10 February 2016 to 25 August 2026, the count stands at 44 filings.

The open-market side counts 2 purchases for €1.9M alongside 7 sales for €26.7M. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 15 share grants and 6 option exercises. Since January 2026: no purchases and 3 sales on the market.

Most recently, on 27 August 2026, the filings show an option exercise worth €3.5M in Charles River Laboratories International, Inc. The last insider purchase was made public on 21 February 2025, 604 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.